In contrast, elevated levels of TMED2 were found in ovarian carcinoma patients (Shi-peng et al., 2017), and ectopic expression of TMED2 in ovarian cancer cells resulted in increased cell proliferation and cell migration, characteristic of metastatic cells. This evidence concerns the gene TMED2 and ovarian cancer.